NUCALA (mepolizumab) is for the add-on treatment of patients 6+ with severe eosinophilic asthma. Not for acute bronchospasm or status asthmaticus.

Please See Important Safety Information Below

From spending time on the driving range to sitting at home instead of the waiting room, learn what the NUCALA Autoinjector can mean for your patients.

MPLWCNT210111 October 2021
Produced in USA.